BEUDAMED
    FDA Adverse Event Injury Summary report: N

    EUFLEXXA INJ 10 MG/ML

    MDR report key: 7049314 · Received November 21, 2017

    Report

    Report Number
    MW5073481
    Event Type
    Injury
    Date Received
    November 21, 2017
    Date of Event
    September 25, 2017
    Report Date
    November 16, 2017
    Manufacturer
    FERRING PHARMACEUTICALS, INC.
    Product Code
    MOZ
    UDI-DI
    55566410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    SPOKE TO PT REGARDING SIDE EFFECTS SHE HAS BEEN EXPERIENCING DURING THE COURSE OF HER MOST RECENT SERIES OF EUFLEXXA INJECTIONS. SHE STARTED TO EXPERIENCE NOTICEABLY MORE SWELLING AND PAIN IN BOTH HER KNEES BETWEEN THAT FIRST AND SECOND WEEK OF INJECTIONS, AND EVEN MORE SWELLING BETWEEN THE SECOND AND THIRD WEEK OF INJECTIONS. SHE ADVISED THE MDO OF HER ISSUES AND CONCERNS, UPON WHICH THEY TOLD HER "GIVE IT SOME TIME FOR THE INJECTIONS TO TAKE AFFECT."

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    829608 EUFLEXXA INJ 10 MG/ML EUFLEXXA INJ 10 MG/ML MOZ FERRING PHARMACEUTICALS, INC. 55566410001

    Patients

    Seq Age Sex Outcome Treatment
    1 61 YR